Josiah Craver
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Josiah Craver currently works at Sensei Biotherapeutics, Inc., as SVP-Finance, Chief Financial & Accounting Officer from 2024.
Mr. Craver also formerly worked at Kala Bio, Inc., as Senior Vice President & Controller and Solid Biosciences, Inc., as Vice President-Finance in 2020.
Mr. Craver received his undergraduate degree and graduate degree from Stonehill College, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Director Financiero/CFO | 17/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Comptroller/Controller/Auditor | 01/03/2020 |
| KALA BIO, INC. | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Kala Bio, Inc.
Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Stonehill College, Inc.
Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.